SLE Vasculitis In Egyptian Patients

  • STATUS
    Recruiting
  • days left to enroll
    63
  • participants needed
    20
  • sponsor
    Tabarak New Cairo Hospital (TNCH)
Updated on 26 January 2021

Summary

Systemic lupus erythematosus (SLE) is a complex heterogeneous autoimmune disease with a wide variety of clinical and serological manifestations that may affect any organ. Vasculitis prevalence in SLE is reported to be between 11% and 36%.

Description

Systemic lupus erythematosus (SLE) is a complex heterogeneous autoimmune disease with a wide variety of clinical and serological manifestations that may affect any organ. Vasculitis prevalence in SLE is reported to be between 11% and 36%. A diverse clinical spectrum, due to inflammatory involvement of vessels of all sizes, is present. Even though cutaneous lesions, representing small vessel involvement, are the most frequent, medium and large vessel vasculitis may present with visceral affection, with life-threatening manifestations such as mesenteric vasculitis, pulmonary hemorrhage, or mononeuritis multiplex, with detrimental consequences. Early recognition and an appropriate treatment are crucial. Recent studies have shown that vasculitis in patients with SLE may present different clinical forms based on the organ involved and the size of the affected vessel. It is noteworthy that the episodes of vasculitis are not always accompanied by high disease activity. Recent articles on this topic have focused on new treatments for the control of vascular disease, such as biological therapies such as Rituximab and Belimumab, among others.

Details
Condition Vasculitis Lupus
Treatment Vasculitis In SLE
Clinical Study IdentifierNCT04386889
SponsorTabarak New Cairo Hospital (TNCH)
Last Modified on26 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

LE or suspected SLE established by ACR criteria
Ability to give informed consent
Adult and minor relatives (first and second degree) of individuals Included in IV-G (only for genetic studies)
Ability of the patient or minor relative s parents to give informed consent
Affected individuals age greater than or equal to 9 years with no upper age limit
Healthy Volunteers (non-related) age greater than or equal to 18 with no upper age limit
Healthy Volunteers (first- and second-degree relatives) age greater than or equal to 9 with no upper age limit
Vascular studies adults only age greater than or equal to 18 with no upper age limit

Exclusion Criteria

Concomitant medical problems which would confound the interpretation of studies gathered by this protocol. Included in this is the presence of HIV in the blood, active malignancies, or other significant medical conditions that may interferes with interpretation of some lupus studies
Concomitant medical, surgical or other conditions for which inadequate facilities are available to support their care at NIH
Inability or unwillingness to comply with follow up requirements (e.g
distance, social, physical limitations)
Any comorbidity of medical or psychological/psychiatric condition or treatment after reviewing of patients previous or outside medical records, that in the opinion of the Principal Investigator, would exclude the subjects from the research studies (e.g. Patient requiring urgent and/or acute medical care, surgical or other procedures)
Unwilling to participate in research studies or to provide research samples or data
Criteria for exclusion
Any concomitant medical problems or are taking medications which would confound the interpretation of studies they are considered for
EXCLUSION CRITERIA FOR VASCULAR STUDIES ONLY, FOR SLE AND HEALTHY
CONTROLS
Subjects with a contraindication to MRI scanning will not receive the optional Cardiovascular MRI. These contraindications include subjects with the following
devices
Central nervous system aneurysm clips unless it is labeled safe or conditional for MRI
Implanted neural stimulator (e.g.TENS-Unit) unless it is labeled safe or conditional for MRI
Implanted cardiac pacemaker or defibrillator
Cochlearor any type of ear implant unless it is labeled safe or conditional for MRI
Ocular foreign body (e.g. metal shavings)
Implanted Insulin pump or drug infusion device unless it is labeled safe or conditional for MRI
Metal shrapnel or bullet unless cleared by plain x-ray as safe for MRI
Subjects with renal excretory dysfunction, estimated glomerular filtration rate < 60 mL/min/1.73m(2) using the CKD-EPI equation or equivalent (using the CRIS-calculated eGFR to define the threshold) and a serum creatinine measured within 2 weeks without intercurrent change in medical condition or medications. Subjects meeting this exclusion criterion may still be included in the study but will not be exposed to the cardiac CT angiography, or gadolinium-based contrast agents
Any clinical instability precluding subject from getting MRI as determined by the enrolling clinician
Pregnant or lactating women will be excluded from vascular studies
Healthy controls with known history of coronary artery disease, peripheral vascular disease or atherosclerosis
Individuals younger than 18 years old will be excluded given the radiation exposure as well as the lack of proper validation for the proposed vascular function studies
Clear my responses

How to participate?

Step 1 Connect with a site
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar
Name

Primary Contact

site
Name

Phone Email

0/250
Preferred Language
Other Language
Please verify that you are not a bot.

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note